Table 3.

Multivariable ^† assessment of primary outcomes, significant\\ predictors of outcome

	OR	95% CI	p-value
Time to Regular Diet
Alvimopan	3.81	1.40–10.36	<0.01
pN+	0.20	0.05–0.82	0.03
Length of Stay
Alvimopan	2.98	1.09–8.20	0.03
Female Gender	0.06	0.005–0.79	0.03

 ^†Variables assessed: Age, Receipt of Alvimopan, Gender, Race, Stage, Neoadjuvant Chemotherapy, Surgery Type, and Diversion.